Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
MoonLake Immunotherapeutics - Class A Ordinary Shares
(NQ:
MLTX
)
47.25
-0.79 (-1.64%)
Streaming Delayed Price
Updated: 10:34 AM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about MoonLake Immunotherapeutics - Class A Ordinary Shares
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 31, 2023
Via
Benzinga
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
August 31, 2023
Needham initiated coverage on MoonLake Immunotherapeutics (NASDAQ: MLTX) with a Buy rating and
Via
Benzinga
Expert Ratings for MoonLake
August 31, 2023
Via
Benzinga
10 Analysts Have This to Say About MoonLake
August 14, 2023
Via
Benzinga
Analyst Expectations for MoonLake's Future
July 26, 2023
Via
Benzinga
Where MoonLake Stands With Analysts
July 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
August 31, 2023
Via
Benzinga
The 7 Most Promising Momentum Stocks to Own Now
August 31, 2023
These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility.
Via
InvestorPlace
10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More
July 18, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
Why MoonLake Immunotherapeutics Stock Skyrocketed This Week
June 29, 2023
Positive mid-stage results fueled a spike in the biotech's shares this week.
Via
The Motley Fool
Why Shares of MoonLake Immunotherapeutics Skyrocketed Monday
June 26, 2023
The company reported positive phase 2 clinical trial results.
Via
The Motley Fool
Price Target For MoonLake Doubled: Analyst Says Lead Program Has 'Best-In-Class Profile'
July 17, 2023
HC Wainwright has increased the price target for MoonLake Immunotherapeutics (NASDAQ: MLTX) from $37 to $75
Via
Benzinga
Ford Motor Cuts Prices For F-150 Lightning Truck, Microsoft-Sony Sign Agreement for 'Call of Duty,' Alibaba Stock Slips on China's Q2 GDP Sentiment: Today's Top Stories
July 17, 2023
Benzinga
Via
Benzinga
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
July 17, 2023
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for...
Via
Benzinga
10 Short Squeeze Stocks To Watch: Asset Entities, Lightning eMotors, Bullfrog AI, Carvana And More
July 10, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
$40M Bet On MoonLake Immunotherapeutics? Check Out These 3 Stocks Insiders Are Buying
July 06, 2023
Although US stocks closed lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 04, 2023
Via
Benzinga
10 Short Squeeze Stocks To Watch: A Leader That Moved Up 392 Positions, Intuitive Machines, Toro And More
July 03, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review
June 30, 2023
Major indexes rebounded strongly and many stocks flashed buy signals.
Via
Investor's Business Daily
Why MoonLake Immunotherapeutics Was Such a Healthy Stock Today
June 27, 2023
The heavily bullish sentiment on the company only grew on the second trading day of the week.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 27, 2023
Via
Benzinga
MoonLake Immunotherapeutics, Applied Digital And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
June 27, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Dow Surges Over 50 Points; Avalo Therapeutics Shares Plummet
June 26, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining more than 50 points on Monday. The Dow traded up 0.18% to 33,788.05 while the NASDAQ fell 0.61% to 13,410.63. The S&P 500,...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 26, 2023
Via
Benzinga
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 26, 2023
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...
Via
Benzinga
Crude Oil Rises; Carnival Shares Drop After Q2 Results
June 26, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 80 points on Monday. The Dow traded down 0.02% to 33,719.54 while the NASDAQ fell 0.53% to 13,420.67. The S&P 500, also...
Via
Benzinga
Is the Stock Market Closed on the Fourth of July 2023?
June 26, 2023
Investors are looking for information about the stock market being closed on the Fourth of July and we've got the answers they seek!
Via
InvestorPlace
Is the Stock Market Closed on July 3, 2023?
June 26, 2023
Investors are preparing for Independence Day and that has some traders wondering if the stock market is closed on July 3, 2023.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.